Syros Pharmaceuticals Inc (NASDAQ:SYRS) Rises 73.32% In 2024; Is It Still Attractive At $0.20?
In last trading session, Syros Pharmaceuticals Inc (NASDAQ:SYRS) saw 1.54 million shares changing hands with its beta currently measuring 1.33. Company’s recent per share price